IN VITRO EFFICACY STUDY EVALUATION OF THE ABILITY OF A MEDICAL DEVICE TO DISRUPT AND PERMEATE A MODEL PHOSPHOLIPID BILAYER MEMBRANE.
ViruBLOC Nasal Microgel Spray Ref. 2101134R6
Report N. V.E.IT.SI.NAS00.000.00.00_IT0000120/21_B dated 19/03/2021 Complife Italia Srl
PURPOSE OF THE STUDY
Evaluation of the ability of a medical device to damage the structure of a bilayer membrane, causing the leakage of a fluorescent marker.
CONCLUSIONS
According to the experimental data reported in this report and to the applied experimental protocol,
ViruBLOC Nasal Microgel Spray 2101134R6 is able to significantly disrupt and permeate a model biomimetic phospholipid membrane.
Image
